Plasmalogen S capsules 1.0 mg for brain activity and Alzheimer’s disease (tamotsu)
What are Plasmalogen S capsules 1.0 mg for brain activation and Alzheimer's disease?
Lipids constitute more than 50% of the dry weight of the human brain, and among those lipids, phospholipids are particularly important for various cell membrane functions, including vesicular and neurotransmitter release, synaptic function, and vesicular-to-cell fusion. Plasmalogens are a type of glycerophospholipids that actively participate in modulating membrane fluidity, lipid packing within lipoproteins, and interactions with neural receptors and ion channels. However, with the aging process, the levels of plasmalogens naturally decline, thereby establishing a strong correlation between their depletion and the onset and progression of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases.
Plasmalogen S capsules are formulated using high-purity plasmalogens derived from scallops. The entire manufacturing process adheres to strict quality standards and takes place exclusively in a GMP certified facility located in Japan. Multiple research studies have yielded encouraging outcomes regarding the utilization of plasmalogen supplementation in the treatment of Alzheimer's disease. Specifically, investigations conducted by B&S Corporation have revealed the efficacy of Plasmalogen S capsules in improving memory and preventing the onset of Alzheimer's disease, particularly in elderly individuals.
Active principles: plasmalogen from scallop extract 0.5 mg in 1 capsule
Amount: 60 capsules
Maker: B&S Corporation, Tokyo, Japan
Indications:
- supporting healthy brain activity
- memory improvement,
- prevention of age-related dementia and Alzheimer's disease,
- improving symptoms of Alzheimer's disease.
How to take
Take 2 capsules a day with water. Do not chew the capsules.
Contraindications: pregnant and breastfeeding women should consult with their doctor before use.
Important information
Do not store in the fridge.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.